Feb 9 (Reuters) - Ajanta Pharma Ltd:
* SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA FROM 5TH TO 9TH FEBRUARY
* SAYS NO FORM 483 WAS ISSUED TO CO Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.